Bionexus Gene Lab Stock Statistic Functions Beta
| BGLC Stock | USD 2.39 0.11 4.82% |
| Symbol |
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on BioNexus Gene Lab correlated with the market. If Beta is less than 0 BioNexus Gene generally moves in the opposite direction as compared to the market. If BioNexus Gene Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioNexus Gene Lab is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioNexus Gene is generally in the same direction as the market. If Beta > 1 BioNexus Gene moves generally in the same direction as, but more than the movement of the benchmark.
BioNexus Gene Technical Analysis Modules
Most technical analysis of BioNexus Gene help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioNexus from various momentum indicators to cycle indicators. When you analyze BioNexus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About BioNexus Gene Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BioNexus Gene Lab. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioNexus Gene Lab based on widely used predictive technical indicators. In general, we focus on analyzing BioNexus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioNexus Gene's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of BioNexus Gene's intrinsic value. In addition to deriving basic predictive indicators for BioNexus Gene, we also check how macroeconomic factors affect BioNexus Gene price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNexus Gene Lab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Will Specialty Chemicals sector continue expanding? Could BioNexus diversify its offerings? Factors like these will boost the valuation of BioNexus Gene. Projected growth potential of BioNexus fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every BioNexus Gene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of BioNexus Gene Lab is measured differently than its book value, which is the value of BioNexus that is recorded on the company's balance sheet. Investors also form their own opinion of BioNexus Gene's value that differs from its market value or its book value, called intrinsic value, which is BioNexus Gene's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because BioNexus Gene's market value can be influenced by many factors that don't directly affect BioNexus Gene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between BioNexus Gene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BioNexus Gene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, BioNexus Gene's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.